Ligand Binding Studies of Caspase 3 Protein with Compounds of Bacopa monneri - A Target Protein Responsible for Alzheimer's Disease (AD)

被引:0
|
作者
Johari, Surabhi [1 ]
Sinha, Subrata [1 ]
Bora, Sewali [1 ]
Biswas, Sagarika [2 ]
Gupta, Khushboo [1 ]
机构
[1] Dibrugarh Univ, Ctr Bioinformat Studies, Dibrugarh, Assam, India
[2] Univ Delhi, CSIR Lab, Inst Genom & Integrat Biol, Delhi, India
来源
GLOBAL TRENDS IN COMPUTING AND COMMUNICATION SYSTEMS, PT 1 | 2012年 / 269卷
关键词
Alzheimer's Disease; Caspases; CASP; 3; Bacopa monneri; Ligand; STRUCTURE-PROPERTY; ACCURACY; DOCKING;
D O I
暂无
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Alzheimer's disease (AD) is a type of dementia that causes problems with memory, thinking and behaviour. It has been discovered that APP (amyloid precursor protein) is a precusor molecule whose proteolysis generate amyloid B (AB) amino acid peptide. AB is an amyloidogenic peptide that forms senile plaques found in the brains of AD. Evidence suggests that senile plaques are formed due to the activation of Caspases particulary caspases CASP 3 and CASP 4. Bacopa monneri has been in use since early as a brain tonic to enhance memory development, however how the components of Bacopa monneri function is yet unknown In this paper an attempt has been made to establish the components activities insilico with CASP 3. We found that among the screened seven compounds Ligand 6 interacts potentially with CASP 3 and has passed all the properties of drug with drug likeliness 0.95, drug score 0.69, highly soluble, highly permeable, non mutagenic, non tumerogenic and non irritant.
引用
收藏
页码:37 / +
页数:3
相关论文
共 50 条
  • [31] Innate Immunity Protein IFITM3 in Alzheimer's Disease
    Hur, Ji-Yeun
    DNA AND CELL BIOLOGY, 2021, 40 (11) : 1351 - 1355
  • [32] Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease
    Puchades, M
    Hansson, SF
    Nilsson, CL
    Andreasen, N
    Blennow, K
    Davidsson, P
    MOLECULAR BRAIN RESEARCH, 2003, 118 (1-2): : 140 - 146
  • [33] Protein Phosphatase 2A as a Drug Target in the Treatment of Cancer and Alzheimer’s Disease
    Hui Wei
    Hui-liang Zhang
    Jia-zhao Xie
    Dong-li Meng
    Xiao-chuan Wang
    Dan Ke
    Ji Zeng
    Rong Liu
    Current Medical Science, 2020, 40 : 1 - 8
  • [34] CCAAT/enhancer binding protein δ (C/EBPδ) expression and elevation in Alzheimer's disease
    Li, RN
    Strohmeyer, R
    Liang, Z
    Lue, LF
    Rogers, J
    NEUROBIOLOGY OF AGING, 2004, 25 (08) : 991 - 999
  • [35] Changes of neurocalcin, a calcium-binding protein, in the brain of patients with Alzheimer's disease
    Shimohama, S
    Chachin, M
    Taniguchi, T
    Hidaka, H
    Kimura, J
    BRAIN RESEARCH, 1996, 716 (1-2) : 233 - 236
  • [36] Model of Alzheimer's disease amyloid-β peptide based on a RNA binding protein
    Mathura, VS
    Paris, D
    Ait-Ghezala, G
    Quadros, A
    Patel, NS
    Kolippakkam, DN
    Volmar, CH
    Mullan, MJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 332 (02) : 585 - 592
  • [37] TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis
    Vatsavayi, Anil Varma V.
    Kofler, Julia
    DeMichele-Sweet, Mary Ann A.
    Murray, Patrick S.
    Lopez, Oscar L.
    Sweet, Robert A.
    INTERNATIONAL PSYCHOGERIATRICS, 2014, 26 (06) : 987 - 994
  • [38] Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents
    Jouanne, Marie
    Rault, Sylvain
    Voisin-Chiret, Anne-Sophie
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 139 : 153 - 167
  • [39] p38 mitogen activated protein kinase as a therapeutic target for Alzheimer’s disease
    Stacie A. Dalrymple
    Journal of Molecular Neuroscience, 2002, 19 : 295 - 299
  • [40] p38 mitogen activated protein kinase as a therapeutic target for Alzheimer's disease
    Dalrymple, SA
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2002, 19 (03) : 295 - 299